Conference
A phase 2 randomized, double-blind, placebo-controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitors
Authors
Crowther M; Kitt M; Lorenz T; Mathur V; Lu G; Hutchaleelaha A; Hollenbach S; Curnutte J; Becker RC
Volume
11
Pagination
pp. 30-30
Publisher
WILEY-BLACKWELL
Publication Date
July 1, 2013
Conference proceedings
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
ISSN
1538-7933